𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

✍ Scribed by Tim Sparwasser; Ramunas M. Vabulas; Brigitte Villmow; Grayson B. Lipford; Hermann Wagner


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
142 KB
Volume
30
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Receptors for conserved molecular patterns associated with microbial pathogens induce synthesis of co-stimulatory molecules and cytokines in immature dendritic cells (DC), as do antigen-reactive CD4 T helper cells via CD40 signaling. Once activated, antigen-presenting DC may activate CD8 T cell responses in a T helper cell-independent fashion. Using immunostimulatory CpG-oligonucleotides (ODN) mimicking bacterial CpG-DNA, we tested whether CpG-DNA bypasses the need for T helper cells in CTL responses towards proteins by directly activating antigen-presenting DC to transit into professional APC. We describe that immature DC in situ constitutively process soluble proteins and generate CD8 T cell determinants yet CD8 T cell responses remain abortive. Induction of primary antigen-specific CD8 cytotoxic T lymphocyte (CTL)-mediated responses becomes initiated in wild-type as well as T helper cell-deficient mice, provided soluble protein and CpG-ODN are draining into the same lymph node. Specifically we show that CpG-ODN trigger antigen-presenting immature DC within the draining lymph node to acutely up-regulate co-stimulatory molecules and produce IL-12. These results provide new insights for generating in vivo efficient CTL responses to soluble proteins which may influence vaccination strategies.


📜 SIMILAR VOLUMES


Recombinant gp100 protein presented by d
✍ Björn Cochlovius; Michael Linnebacher; Monika Zewe-Welschof; Margot Zöller 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB 👁 2 views

Induction of a helper T (TH)-cell response is a critical element in the generation of anti-tumor immunity. The majority of immunotherapeutic approaches have so far been concerned with the generation of cytotoxic T lymphocytes (CTLs). This also accounts for gp100, a melanoma-associated protein which